FDA blood glucose test strip alert not received by 38% of pharmacists in OIG survey.
This article was originally published in The Gray Sheet
Executive SummaryFDA BLOOD GLUCOSE TEST STRIP ALERT NOT RECEIVED BY 38% OF PHARMACISTS surveyed via phone by HHS' Office of the Inspector General, according to a July 17 OIG report. Examining the effectiveness of an Oct. 11, 1995 FDA safety alert on defective blood glucose test strips manufactured by Diagnostic Solutions, the OIG audit of 462 pharmacies nationwide found that just over 60% of the vendors "acknowledged receiving" the FDA notice.
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.